Eric H. Bjerholt is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Apr 2009: SUNESIS PHARMACEUTICALS INC (South San Francisco, CA — pharmaceuticals — 2009; $28.5M reported sold to 18 investors).
What this means One deal on file with the SEC, filed Apr 2009. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Eric H. Bjerholt and found 2 differences: Bankruptcy case: Misfeldt v. JPMorgan Chase Bank, N.A; No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.